You searched for "Robot"
In conversation with Tim O’Brien
We were delighted to catch up with Tim O’Brien, President of BAUS, about his career highlights and plans for the association. Can you tell us a little bit about what led you into the field of urology and the highlights...How to conduct an endoscopic séance
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I agreed to tell you how to conduct an...Going for Gold… and Girth: Olympic rumours, and the new BAUS consensus on penile augmentation
The Winter Olympics are a bewildering spectacle at the best of times, particularly for causal quadrennial viewers of alpine sports such as myself. Personal highlights of this year’s iteration in Milano-Cortina included the superhuman performance of the Norwegian Johannes Klaebo...The pioneer women in British urology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). This month, I am joined by Kassie Ball, a urology trainee, who approached...Digital Twins: From NASA to the clinic
Clinical practice generates an enormous amount of patient data – histories, observations, blood results, imaging and molecular biomarkers. The problem is that these data streams rarely talk to each other. Instead, we use them in isolation, when what we actually...Students for Urology: a new national society aimed at improving undergraduate exposure
As medical students, we were surprised at just how little urological content was taught at medical school. We received a basic education on how to manage urological infections, renal stones and urinary retention but nothing particularly inspiring was shared, nothing...
SUSPEND suspended MET
This review is on the recent groundbreaking evidence on medical expulsive therapy (MET). MET using alpha adrenergic blockers (like tamsulosin) are in regular clinical practice. Even though it is an off label prescription, it is well accepted and practised world...
Anti-VEGF and PD-1 combinations in renal cell carcinoma
Over the past decade, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs) have been central to treating renal cell carcinoma (RCC), with oncologists refining dosing strategies to balance treatment efficacy with quality of life (QoL). Recently, the introduction of...
